[1] |
张君.初孕妇妊娠糖尿病和产后糖尿病发病的影响因素研究[J].中国妇幼卫生杂志,2015,6(3):14-17.
|
[2] |
田丽,杨柳,裴继艳,等.2 型糖尿病周围神经病变相关危险因素分析[J].山西医科大学学报,2015,46(1):58-61.
|
[3] |
Boulton AJ,Vinik AI,Arezzo JC,et al.Diabetic Neuropathies:a statement by the American Diabetes Association[J].Diabetes Care,2005,28(4):956-962.
|
[4] |
Stang A.Critial evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysis[J].Eur J Epidemol,2010,25(9):603-605.
|
[5] |
曾宪涛,刘慧,陈曦,等.Meta 分析系列之四:观察性研究的质量评价工具[J].中国循证心血管医学杂志,2012,4(4):297-299.
|
[6] |
陈晓倩,毕艳,胡云,等.糖尿病周围神经病变患病率及危险因素分析[J].医学研究生学报,2011,24(10):1035-1038.
|
[7] |
赫广玉,孙成林,刘玉佳,等.糖尿病周围神经病变神经损害特点及相关因素分析[J].中国糖尿病杂志,2014,22(2):118-121.
|
[8] |
陈晓文,马红英,陈勇伟,等.2 型糖尿病患者周围神经病变危险因素分析[J].中国糖尿病杂志,2014,22(12):1057-1059.
|
[9] |
陈兰英,郑芬萍,李红.2 型糖尿病周围神经病变患者血清胱抑素C 水平临床意义[J].中国糖尿病杂,2014,22(8):700-703.
|
[10] |
Xu F,Zhao LH,Su JB,et al.The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c[J].Diabetol Metab Syndr,2014,6(1):139.
|
[11] |
Shen J,Liu M,Liu X,et al.Relationship between postprandial C-peptide level and diabetic peripheral neuropathy in Chinese type 2 diabetes patients[J].Int J Clin Exp Pathol,2016,9(9):9318-9124.
|
[12] |
万慧,蒋晓红,王龙,等.新诊断2 型糖尿病C 肽水平与2 型糖尿病周围神经病变的相关性分析[J].中国糖尿病杂志,2017,25(6):514-517.
|
[13] |
魏薇,王中京,周玲,等.2 型糖尿病周围神经病变的危险因素分析[J].海南医学,2017,25(6):514-517.
|
[14] |
胡方舟,杨雯月,谢小红,等.2 型糖尿病患者合并周围神经病变的危险因素分析[J].中华全科医学,2018,16(5):781-784.
|
[17] |
阿地拉·阿不都外力,伊力哈木江·依马木.2 型糖尿病患者并发糖尿病周围神经病变的临床特征及相关危险因素分析[J].世界最新医学信息文摘,2019,19(8):14-17.
|
[18] |
朱佳杰,柴欣楼,张永生.2 型糖尿病血管内皮损伤与内质网应激[J].生理科学进展,2014,45(1):72-74.
|
[22] |
刘茜,吴佳佳,王菊梅,等.皮肤晚期糖基化终末产物与2 型糖尿病周围神经病变的相关性研究[J].安徽医学,2015,36(12):1451-1453.
|
[15] |
Hu YM,Zhao LH,Zhang XL,et al.Association of glycaemic variability evaluated by continuous glucose monitoring with diabetic peripheral neuropathy in type 2 diabetic patients[J].Endocrine,2018,60(2):292-300.
|
[16] |
Su JB,Zhao LH,Zhang XL,et al.HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients[J].Cardiovasc Diabetol,2018,17(1):47.
|
[19] |
Wong TY,Cheung N,Islam FM,et al.Relation of retinopathy to coronary artery calcification[J].Am J Epidemiol,2008,167(1):51-58.
|
[20] |
Wang L,Wong TY,Sharrett AR,et al.Relationship between relation arteriolar narrowing and myocardial perfusion:multiethnic study of atherosclerosis[J].Hypertension,2008,5(1):11-13.
|
[21] |
Monnier L,Mas E,Ginet C,et al.Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes[J].JAMA,2006,295(14):1681-1687.
|
[23] |
刘瑶霞,陈平.高血糖神经毒性研究进展[J].西部医学,2009,21(10):1804-1805.
|
[24] |
Iiasson B.Cigarette smoking and diabetes[J].Prog Cardiovasc Dis,2003,45(5):405-413.
|
[25] |
Papanas N,Ziegler D.Risk Factors and Comorbidities in Diabetic Neuropathy:An Update 2015[J].RDS,2015,12(1-2):48-62.
|
[26] |
Naqvi IH,Talib A,Akhter ST,et al.Peripheral Neuropathy and Vasculopathy,Frequency and Associated Risk Factors in Newly Diagnosed Treatment Naive Type 2 Diabetes[J].Open J Endocr Metab Dis,2018,8(5):125-136.
|
[27] |
Skalli S,Muller M,Pradines S,et al.Vitamin D deficiency and peripheral diabetic neuropathy[J].Eur J Intern Med,2012,23(2):e67-e68.
|